RT Journal Article
SR Electronic
T1 Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer
JF Cancer Biology and Medicine
JO Cancer Biol Med
FD China Anti-Cancer Association
SP 307
OP 327
DO 10.20892/j.issn.2095-3941.2020.0072
VO 17
IS 2
A1 Li, Yanan
A1 Xin, Jingqi
A1 Sun, Yongbing
A1 Han, Tao
A1 Zhang, Hui
A1 An, Feifei
YR 2020
UL http://www.cancerbiomed.org/content/17/2/307.abstract
AB Colorectal cancer (CRC) is the most common gastrointestinal tract cancer worldwide and is associated with high morbidity and mortality. The development of nanosized drug delivery systems has provided a new direction in CRC treatment. Among these systems, magnetic nanoparticle (MNP)-based multifunctional platforms provide a novel strategy for magnetic resonance imaging (MRI)-related cancer theranostics. At the beginning of this original review, the carcinogenesis and treatment status of CRC are summarized. Then, diversified preparation and functionalization methods of MNPs are systematically analyzed, followed by MRI-involved theranostic strategies. The latest progress in MRI-mediated multimode diagnosis and image-guided targeted therapy in CRC management is the main focus. Finally, the major challenges in promoting MRI-induced precise theranostics of CRC in clinical practice are discussed.